165 related articles for article (PubMed ID: 15730405)
1. Imbalance in the production between vascular endothelial growth factor and endostatin in Kawasaki disease.
Takeshita S; Kawamura Y; Takabayashi H; Yoshida N; Nonoyama S
Clin Exp Immunol; 2005 Mar; 139(3):575-9. PubMed ID: 15730405
[TBL] [Abstract][Full Text] [Related]
2. Increased serum levels of vascular endothelial growth factor in Kawasaki disease.
Maeno N; Takei S; Masuda K; Akaike H; Matsuo K; Kitajima I; Maruyama I; Miyata K
Pediatr Res; 1998 Oct; 44(4):596-9. PubMed ID: 9773852
[TBL] [Abstract][Full Text] [Related]
3. [Changes of P-selectin and E-selectin in children with Kawasaki disease].
Qiu Y; Wu J; Fang XY; Lin Z; Wu BY; Cai RY; Xu XY; Zheng H
Zhonghua Er Ke Za Zhi; 2004 Sep; 42(9):688-92. PubMed ID: 15482673
[TBL] [Abstract][Full Text] [Related]
4. Neutrophils and mononuclear cells express vascular endothelial growth factor in acute Kawasaki disease: its possible role in progression of coronary artery lesions.
Hamamichi Y; Ichida F; Yu X; Hirono KI; Uese KI; Hashimoto I; Tsubata S; Yoshida T; Futatani T; Kanegane H; Miyawaki T
Pediatr Res; 2001 Jan; 49(1):74-80. PubMed ID: 11134495
[TBL] [Abstract][Full Text] [Related]
5. [Clinical value of serum matrix metalloproteinase-9 and tissue inhibitor of metalloproteinase-1 for the prediction and early diagnosis of coronary artery lesion in patients with Kawasaki disease].
Peng Q; Zhou TF; Chen CH; Hua YM; Liu HM; Hong H; Zhang LY; Wu Q
Zhonghua Er Ke Za Zhi; 2005 Sep; 43(9):676-80. PubMed ID: 16191301
[TBL] [Abstract][Full Text] [Related]
6. Association of vascular endothelial growth factor (VEGF) and VEGF receptor gene polymorphisms with coronary artery lesions of Kawasaki disease.
Kariyazono H; Ohno T; Khajoee V; Ihara K; Kusuhara K; Kinukawa N; Mizuno Y; Hara T
Pediatr Res; 2004 Dec; 56(6):953-9. PubMed ID: 15470196
[TBL] [Abstract][Full Text] [Related]
7. [Matrix metalloproteinase-1 expression in the circulation of patients with Kawasaki disease and its role in the pathogenesis of coronary artery lesions].
Yang SW; Wang DW; Li J; Qin YM; Wang FM; Cao LM; Zhang LF; Hu Z
Zhonghua Er Ke Za Zhi; 2005 Aug; 43(8):612-5. PubMed ID: 16191276
[TBL] [Abstract][Full Text] [Related]
8. Serum hepatocyte growth factor combined with vascular endothelial growth factor as a predictive indicator for the occurrence of coronary artery lesions in Kawasaki disease.
Ohno T; Yuge T; Kariyazono H; Igarashi H; Joh-o K; Kinugawa N; Kusuhara K; Hara T
Eur J Pediatr; 2002 Feb; 161(2):105-11. PubMed ID: 11954744
[TBL] [Abstract][Full Text] [Related]
9. Correlations of complication with coronary arterial lesion with VEGF, PLT, D-dimer and inflammatory factor in child patients with Kawasaki disease.
Zhou Y; Wang S; Zhao J; Fang P
Eur Rev Med Pharmacol Sci; 2018 Aug; 22(16):5121-5126. PubMed ID: 30178831
[TBL] [Abstract][Full Text] [Related]
10. Increased production of vascular endothelial growth factor-d and lymphangiogenesis in acute Kawasaki disease.
Ebata R; Abe J; Yasukawa K; Hamada H; Higashi K; Suwazono Y; Saito H; Terai M; Kohno Y
Circ J; 2011; 75(6):1455-62. PubMed ID: 21483160
[TBL] [Abstract][Full Text] [Related]
11. Correlation between brachial artery flow-mediated dilation and endothelial microparticle levels for identifying endothelial dysfunction in children with Kawasaki disease.
Ding YY; Ren Y; Feng X; Xu QQ; Sun L; Zhang JM; Dou JJ; Lv HT; Yan WH
Pediatr Res; 2014 Mar; 75(3):453-8. PubMed ID: 24336465
[TBL] [Abstract][Full Text] [Related]
12. Imbalance between vascular endothelial growth factor and endostatin correlates with the prognosis of operable non-small cell lung cancer.
Hu Y; Hu MM; Shi GL; Han Y; Li BL
Eur J Surg Oncol; 2014 Sep; 40(9):1136-42. PubMed ID: 24998915
[TBL] [Abstract][Full Text] [Related]
13. Vascular endothelial growth factor in acute Kawasaki disease.
Terai M; Yasukawa K; Narumoto S; Tateno S; Oana S; Kohno Y
Am J Cardiol; 1999 Feb; 83(3):337-9. PubMed ID: 10072219
[TBL] [Abstract][Full Text] [Related]
14. A polymorphism in the promoter of the CD14 gene (CD14/-159) is associated with the development of coronary artery lesions in patients with Kawasaki disease.
Nishimura S; Zaitsu M; Hara M; Yokota G; Watanabe M; Ueda Y; Imayoshi M; Ishii E; Tasaki H; Hamasaki Y
J Pediatr; 2003 Sep; 143(3):357-62. PubMed ID: 14517520
[TBL] [Abstract][Full Text] [Related]
15. Circulating endothelial cells in Kawasaki disease.
Nakatani K; Takeshita S; Tsujimoto H; Kawamura Y; Tokutomi T; Sekine I
Clin Exp Immunol; 2003 Mar; 131(3):536-40. PubMed ID: 12605708
[TBL] [Abstract][Full Text] [Related]
16. [Correlation between the ratio of serum vascular endothelial growth factor/endostatin and childhood acute leukemia].
Gu JW; Hu ZD; Liu Z
Zhongguo Dang Dai Er Ke Za Zhi; 2011 Jun; 13(6):475-7. PubMed ID: 21672421
[TBL] [Abstract][Full Text] [Related]
17. [Change in plasma N-terminal pro-brain natriuretic peptide in children with Kawasaki disease and its value in clinical practice].
Zhang QY; Du JB; Chen YH; Li WZ
Zhonghua Er Ke Za Zhi; 2006 Dec; 44(12):886-90. PubMed ID: 17254452
[TBL] [Abstract][Full Text] [Related]
18. [Serum adiponectin levels in children with Kawasaki disease].
Huang M; Dong GQ; Jiang HY; Zhang JY; Shi XJ
Zhongguo Dang Dai Er Ke Za Zhi; 2015 Jan; 17(1):35-9. PubMed ID: 25616290
[TBL] [Abstract][Full Text] [Related]
19. [Clinical significance of anti-neutrophil cytoplasmic antibodies and anti-endothelial cell antibodies in children with Kawasaki disease].
Zhao JM; Wang XH
Zhongguo Dang Dai Er Ke Za Zhi; 2014 Jul; 16(7):740-4. PubMed ID: 25008884
[TBL] [Abstract][Full Text] [Related]
20. MicroRNA-93 may control vascular endothelial growth factor A in circulating peripheral blood mononuclear cells in acute Kawasaki disease.
Saito K; Nakaoka H; Takasaki I; Hirono K; Yamamoto S; Kinoshita K; Miyao N; Ibuki K; Ozawa S; Watanabe K; Bowles NE; Ichida F
Pediatr Res; 2016 Sep; 80(3):425-32. PubMed ID: 27089500
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
